MOR

MorphoSys AG

Price

return (12m)

p/e

-7.94

p/bv

49.27

DIVIDEND YIELD

0.00%

MOR price

MorphoSys

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MOR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals MOR

Valuation

P/E

-7.94

Sector -3.50

Industry -3.50

P/BV

49.27

Sector 2.02

Industry 2.02

P/Revenue (PSR)

9.27

Sector 2.01

Industry 2.01

EV/EBITDA

54.95

Sector -214.99

Industry -214.99

EV/EBIT

54.95

Sector -47.59

Industry -47.59

P/EBITDA

-22.91

Sector -21.41

Industry -21.41

P/EBIT

-21.55

Sector -28.65

Industry -28.65

P/Total Assets

1.19

Sector 1.19

Industry 1.19

P/Net Current Assets

-2.08

Sector -11.97

Industry -11.97

P/Working Capital

4.40

Sector -167.95

Industry -167.95

EPS

-2.39

Sector -1.81

Industry -1.81

BVPS

0.38

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

77.94%

Sector 41.30%

Industry 41.30%

EBITDA Margin

93.34%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

93.34%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-95.49%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.03

Sector 0.02

Industry 0.02

Profitability

ROE

-620.57%

Sector -56.04%

Industry -56.04%

ROA

-15.02%

Sector -60.31%

Industry -60.31%

ROIC

-24.67%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.08

Sector 2.89

Industry 2.89

Net Debt / EBITDA

11.12

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

11.12

Sector -8.06

Industry -8.06

Net Debt / Equity

12.50

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

12.50

Sector -0.85

Industry -0.85

Equity/Assets

0.02

Sector 0.46

Industry 0.46

Liabilities/Assets

0.02

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-83.39%

Sector -

Industry -

5Y Earnings CAGR

-86.90%

Sector -

Industry -

Fundamentals MOR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MOR MorphoSys AG	$0.00	-	0.00%	-7.94	49.27	-620.57%	-100.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MOR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT MorphoSys

MorphoSys AG

Average Investor10 user rating

4.0 (0 people)

United States

34 years

Founded: 1992

2018

Time since IPO - 8 years

615

Employees

MorphoSys AG (United States) is listed on the Nasdaq and has a market capitalization of $2.64 billion, with shareholders equity totaling $53.49 million.

The company employs approximately 615 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, MorphoSys AG reported $284.42 million in revenue, generating net income of $-331.94 million.

Key financial metrics include a P/E ratio of -7.94, a price-to-book (P/B) ratio of 49.27, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MOR.

Market cap

$2.64 billion

Net worth

$53.49 million

$53,490,000.00

Assets

$2.21 billion

$2,209,720,000.00

Total Shares Outstanding

139.00 million

139,000,000

Average Daily Trading Volume

$47.39 Thousand

$47,389.44

Sector

Health Care

Industry

Biotechnology

MOR

MOR revenue and profits

Financial Results MOR

DRAG THE FRAME TO SEE MORE DATA

MOR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of MorphoSys (MOR) today?

A cotação de MorphoSys (MOR) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de MorphoSys (MOR) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de MorphoSys (MOR) e dados de ações do Ibovespa e mercados internacionais.

Quando MorphoSys (MOR) paga dividendos?

MorphoSys (MOR) não distribuiu dividendos no último ano.

Is MorphoSys (MOR) a good investment?

Atualmente, MorphoSys (MOR) está cotada a US$ 0.00, com um P/L de -7.94, representando um desvio de -81% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy MorphoSys (MOR) stock?

Investir em ações de MorphoSys (MOR) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of MorphoSys (MOR) yield today?

A rentabilidade de MorphoSys (MOR) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de MorphoSys (MOR) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

MOR

MorphoSys AG

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment MOR

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING MOR WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT MorphoSys

MorphoSys AG

United States

34 years

2018

615

PROFIT X PRICE MOR

Financial Results MOR

MOR cash flow

Asset, Revenue and Profit Growth - MOR

MOR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions